Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality

Smith, David P; Banks, Emily; Clements, Mark S; Gardiner, Robert A; Armstrong, Bruce K

doi:10.5694/j.1326-5377.2010.tb03438.x

Topics

In reply: The letter by Arnold highlights the practical dilemma facing busy doctors when communicating with patients about whether to screen for various cancers, prostate cancer in particular. There are no easy answers at present, although presentation of both sides of the argument regarding prostate cancer testing helps doctors and patients make a shared decision.1 We believe the following decision-aid show card, written in plain English, is an excellent resource to assist with this: <http://www.cancer.org.au/File/HealthProfessionals/GPprostateshowcard.pdf >.

1 Cancer Epidemiology Research Unit, Cancer Council NSW, Sydney, NSW.
2 National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT.
3 University of Queensland Centre for Clinical Research, Brisbane, QLD.
4 Royal Brisbane and Women's Hospital, Brisbane, QLD.
5 School of Public Health, University of Sydney, Sydney, NSW.

Correspondence: dsmith@nswcc.org.au

Online responses are no longer available. Please refer to our instructions for authors page for more information.